Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate

National Cheng-Kung University

Status: Withdrawn

Conditions: Benign Prostatic Hyperplasia; Prostate Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT02822963

A-ER-105-045

Details and patient eligibility

About

Benign prostatic hyperplasia(BPH) is a common disease in urology among old men. If BPH symptom cannot be controlled by drugs, then transurethral resection of the prostate (TURP), is recommended. Although the procedure is quit safe, these old men often take anticoagulants and antiplatelets to control cardiovascular diseases, which arose some concerns for their bleeding risk. The management of anticoagulation in patients undergoing surgical procedures is challenging because interrupting anticoagulation increases the risk of thrombotic events. At the same time, surgery and invasive procedures have associated bleeding risks that are increased by the anticoagulant administration. Now, the recommendation about anticoagulants and antiplatelets discontinuation had no concrete evidence, especially in TURP. Furthermore, there is no relative studies done in Taiwan population, which calls for further investigation.

Sex: Male

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Admitted to National Cheng Kung University Hospital Urology during the study
• Older than 20 years old
• Agree to participate this study
• Receiving transurethral resection of the prostate for benign prostatic hyperplasia or prostate cancer

Exclusion criteria

• Poor expression ability and without close care givers to answer questions

Trial design

0 participants in 3 patient groups

A

Description:

Non anticoagulant and/or antiplatelet users.

B

Description:

Anticoagulant and/or antiplatelet users that hold their drugs during perioperative periods.

C

Description:

Anticoagulant and/or antiplatelet users that doesn't hold their drugs during perioperative periods.